Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 497, pseudogene (RNU6-497P) is a member of the family of U6 small nuclear RNA pseudogenes. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations affecting their ability to code for proteins or functional RNA molecules[1][4]. RNU6-497P is classified as a noncoding RNA pseudogene with intrinsic sequence similarity to functional U6 small nuclear RNA genes but does not contribute to the formation of the spliceosome and is not known to encode a functional snRNA[1][5]. U6 snRNA itself is a highly conserved component necessary for pre-mRNA splicing in eukaryotes, but RNU6-497P, as a pseudogene, is not involved in such activity[1][5]. Pseudogenes such as RNU6-497P may exert regulatory influences at the DNA or RNA level, occasionally acting as miRNA decoys, siRNA origins, or affecting parental gene expression via epigenetic mechanisms, but there are no specific or direct functional or therapeutic implications established for RNU6-497P itself[4]. There are also no drugs, mechanisms of action, biomarker status, or safety concerns associated with this pseudogene. Summary interpretation: RNU6-497P is a non-functional pseudogene related to U6 small nuclear RNA, with no direct therapeutic, diagnostic, or receptor relevance, but it could participate in regulatory mechanisms typical of some pseudogenes[4]. The gene is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 497, pseudogene (RNU6-497P).